Tag: CLDN18.2 CAR-T update

Home / CLDN18.2 CAR-T update

Categories

CARSgen presents latest data of Satri-cel therapy in ASCO 2024

Results of SATRi-cel therapy CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK) has released the latest findings from the investigator-initiated trial CT041-CG4006 (NCT03874897) of satricabt...
cldn18-2-car-t-update

Scan the code